Westerink B H, Kwint H F, deVries J B
Department of Medicinal Chemistry, University Center for Pharmacy, University of Groningen, The Netherlands.
J Neurosci. 1996 Apr 15;16(8):2605-11. doi: 10.1523/JNEUROSCI.16-08-02605.1996.
Receptor-specific compounds were applied by retrograde microdialysis to the ventral tegmental area (VTA) of the rat brain. The effect of the intrategmental infusions on extracellular dopamine in the ipsilateral nucleus accumbens were recorded with a second microdialysis probe. Intrategmental infusion of muscimol (10-40 microM) or baclofen (50 microM) decreased extracellular dopamine in the nucleus accumbens. Intrategmental infusion of NMDA (1 mM, 15 min) or kainate (50 microM, 15 min) increased extracellular dopamine in the nucleus accumbens. The effects of the excitatory amino acids were suppressed by co-infusion of MK-801 (1 MM), (+)-3-amino-1-hydroxy-2-pyrrolidone [(+)-HA966; 1 mM], (+/-)-3(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP; 100 microM), and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX;300 microM). Intrategmental infusion of of carbachol (50 microM) increased extracellular dopamine in the nucleus accumbens. These results provide evidence for localization of GABAA, GABAB NMDA, non-NMDA, and cholinergic receptors on dopamine neurons in the VTA. Infusions of CPP, (+)-MK-801, (+)-HA966, CNQX, mecamylamine, atropine, or 3-[(3,4-dichlorophenyl)methyl]propyl phosphonic acid (CGP 52432) into the VTA did not modify extracellular dopamine in the nucleus accumbens. Infusion of bicuculline (50 microM) and (-)-sulpiride (50 microM) was followed by an increase in extracellular dopamine in the nucleus accumbens. These data suggest that dopamine neurons in the VTA are tonically inhibited by GABA and dopamine by acting on GABAA, and D2 receptors, respectively. A tonic stimulation by glutamatergic or cholinergic neurons was not detected. Finally, results on A10 neurons are compared with earlier data on A9 neurons. A striking difference was found in that GABAA-dopamine interactions are indirect in the substantia nigra and direct in the VTA.
通过逆行微透析将受体特异性化合物应用于大鼠脑的腹侧被盖区(VTA)。用第二个微透析探针记录VTA内注射对同侧伏隔核细胞外多巴胺的影响。向VTA内注射蝇蕈醇(10 - 40微摩尔)或巴氯芬(50微摩尔)可降低伏隔核中的细胞外多巴胺水平。向VTA内注射N - 甲基 - D - 天冬氨酸(1毫摩尔,15分钟)或谷氨酸钾(50微摩尔,15分钟)可增加伏隔核中的细胞外多巴胺水平。兴奋性氨基酸的作用可被共同注射MK - 801(1毫摩尔)、(+)- 3 - 氨基 - 1 - 羟基 - 2 - 吡咯烷酮[(+)- HA966;1毫摩尔]、(±)- 3(2 - 羧基哌嗪 - 4 - 基)- 丙基 - 1 - 膦酸(CPP;100微摩尔)和6 - 氰基 - 7 - 硝基喹喔啉 - 2,3 - 二酮(CNQX;300微摩尔)所抑制。向VTA内注射卡巴胆碱(50微摩尔)可增加伏隔核中的细胞外多巴胺水平。这些结果为VTA中多巴胺能神经元上GABAA、GABAB、NMDA、非NMDA和胆碱能受体的定位提供了证据。向VTA内注射CPP、(+)- MK - 801、(+)- HA966、CNQX、美加明、阿托品或3 - [[(3,4 - 二氯苯基)甲基]丙基](二乙氧基甲基)膦酸(CGP 52432)不会改变伏隔核中的细胞外多巴胺水平。注射荷包牡丹碱(50微摩尔)和( - )- 舒必利(50微摩尔)后,伏隔核中的细胞外多巴胺水平会升高。这些数据表明,VTA中的多巴胺能神经元分别通过作用于GABAA和D2受体而受到GABA和多巴胺的紧张性抑制。未检测到谷氨酸能或胆碱能神经元的紧张性刺激。最后,将A10神经元的结果与早期关于A9神经元的数据进行了比较。发现一个显著差异,即GABAA - 多巴胺相互作用在黑质中是间接的,而在VTA中是直接的。